These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11444270)

  • 1. Second malignancies in melanoma patients in Thuringia.
    Wolff J; Wollina U
    J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):479-83. PubMed ID: 11444270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second primary malignancies in patients with cutaneous melanoma.
    Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
    Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell skin cancer and the risk of second primary cancers: a cancer registry-based study in Lithuania.
    Krilaviciute A; Vincerzevskiene I; Smailyte G
    Ann Epidemiol; 2016 Jul; 26(7):511-514. PubMed ID: 27262816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
    Katalinic A; Kunze U; Schäfer T
    Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.
    van Bodegraven B; Vernon S; Eversfield C; Board R; Craig P; Gran S; Harwood CA; Keohane S; Levell NJ; Matin RN; Proby C; Rajan N; Rous B; Ascott A; Millington GWM; Venables ZC;
    Br J Dermatol; 2023 May; 188(6):777-784. PubMed ID: 36814132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
    Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
    Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
    Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary melanomas: incidence and outcome.
    Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
    Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
    Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ
    J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
    Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
    Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and pathological aspects of skin cancer in North East of Romania.
    Andrese E; Solovăstru LG; Taranu T; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):457-62. PubMed ID: 25076715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of invasive cancers following basal cell skin cancer.
    Levi F; La Vecchia C; Te VC; Randimbison L; Erler G
    Am J Epidemiol; 1998 Apr; 147(8):722-6. PubMed ID: 9554413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
    Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
    Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications.
    Marghoob AA; Slade J; Salopek TG; Kopf AW; Bart RS; Rigel DS
    Cancer; 1995 Jan; 75(2 Suppl):707-14. PubMed ID: 7804999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
    Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
    Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of other primary tumours in patients with oral cancer in Scotland.
    Crosher R; McIlroy R
    Br J Oral Maxillofac Surg; 1998 Feb; 36(1):58-62. PubMed ID: 9578260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.